Thompson G R, Naoumova R P, Watts G F
Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom.
J Lipid Res. 1996 Mar;37(3):439-47.
The review examines the evidence that the supply of cholesterol available for incorporation into nascent lipoprotein particles exerts a regulatory influence on apolipoprotein (apo) B secretion by the liver. Support for this hypothesis comes both from in vitro experiments and from recent observations in normal subjects and patients with dyslipidemia associated with familial hypercholesterolemia, obesity, noninsulin dependent diabetes mellitus, growth hormone deficiency and cholesteryl ester storage disease. The findings do not negate a role for triglyceride synthesis in determining apoB secretion in very low density lipoprotein, but the inhibitory effects on the latter process of pharmacological blockade of cholesterol synthesis or esterification suggest that it is conditional upon an adequate supply of cholesteryl ester.
本综述探讨了可用于掺入新生脂蛋白颗粒的胆固醇供应对肝脏载脂蛋白(apo)B分泌产生调节影响的证据。这一假说得到了体外实验以及对正常受试者和患有与家族性高胆固醇血症、肥胖、非胰岛素依赖型糖尿病、生长激素缺乏症和胆固醇酯贮积病相关的血脂异常患者的近期观察结果的支持。这些发现并不否定甘油三酯合成在决定极低密度脂蛋白中apoB分泌方面的作用,但胆固醇合成或酯化的药理学阻断对后一过程的抑制作用表明,这取决于胆固醇酯的充足供应。